AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇬🇭
PEMBROLIZUMAB in Ghana
1 product registered with FDA Ghana — 1 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| KEYTRUDA(100MG/4ML) CONCENTRATE FOR SOLUTION FOR INFUSION (PEMBROLIZUMAB 25MG/ML) | UNKNOWN-bce14a4c | — | active | 1 May 2030 |
PEMBROLIZUMAB — FDA Ghana Registration Details
FDA Ghana (Ghana) has 1 registered product containing PEMBROLIZUMAB, of which 1 is currently active. Data is sourced directly from the official FDA Ghana drug register and refreshed daily.
Track PEMBROLIZUMAB registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.